FDA review practices and priorities for drugs used in cancer treatment

Annals of the New York Academy of Sciences

Volumn 949, Issue , 2001, Pages 341-344

  Kobayashi, Ken ^a,b   Delap, Robert J ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b No 32 Kowa Building 2F   (Japan)

Author keywords

Cancer treatment; FDA review; Investigational new drug (IND) application

Indexed keywords

NEW DRUG;

CANCER RESEARCH; CANCER THERAPY; CONFERENCE PAPER; DRUG APPROVAL; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; LAW; PRESCRIPTION;

ARENA;

EID: 0035687034     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb04042.x     Document Type: Conference Paper

References (0)